InvestorsHub Logo
Followers 37
Posts 2259
Boards Moderated 0
Alias Born 05/10/2016

Re: None

Friday, 06/17/2022 11:24:39 PM

Friday, June 17, 2022 11:24:39 PM

Post# of 199768
Although none of us know for sure exactly what will be revealed with the termination of the NDA(s) the reason why IPF Immune was halted remains a mystery. Here is some food for thought ( It is my THOUGHTS that usually get me in trouble lol)
John Rim~
CEO, EVP
Samsung Biologics 2018-present

Roche-Global Product Development
2010-2018

Genentech(subsidiary of Roche)
2004-2010

The point is that executives often build on their past connections and experiences. It is interesting to note that the Swiss based Roche produces Tamiflu. Enzolytics IPF Immune will be its strong competitor. Consider also that ITV-1 is a suspension of IPF and will be seeking EMA approval.
Connect the dots.?? Again, just my opinion.